Allergovit 6-grasses

BIOLOGICAL2 trials

Sponsors

Allergopharma GmbH & Co. KG

Conditions

Allergic RhinoconjunctivitisGrass Pollen AllergyHealthy Volunteers

Phase 2

Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

TerminatedNCT02297490

Allergopharma GmbH & Co. KGAllergic Rhinoconjunctivitis, Healthy Volunteers

Start: 2014-01-31End: 2014-12-31Updated: 2018-01-17

Phase 3

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

CompletedNCT00263601

Allergopharma GmbH & Co. KGGrass Pollen Allergy

Start: 2001-11-30End: 2010-08-31Updated: 2014-06-05